Singapore, Nov. 14 -- Royal Philips, a global leader in health technology has announced the U.S. debut of its new cognitive assessment platform IntelliSpace Cognition. Leveraging the power of artificial intelligence (AI) and Philips' cloud-based HealthSuite Digital Platform, IntelliSpace Cognition provides healthcare professionals with a powerful aid for assessing cognitive impairment.

IntelliSpace Cognition automates and enhances well-established neuropsychological tests, offering new insights for clinicians treating patients with debilitating neurological conditions. It provides direct access to detailed information about a patient's cognition while also providing quantitative longitudinal data to aid in assessing disease progression a...